Institutional investors purchased a net $621.00 shares of ICCC during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 8.47% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEALTHINVEST PARTNERS AB Bought 1.2 Thousand shares of ImmuCell Corp